- ShangPharma Corporation (NYSE: SHP) is trading higher by about 18.5% pre-market on news that their largest shareholder, [ShangPharma] Chairman and Chief Executive Officer Mr. Michael … Continue Reading
Read nowInterviews - Photocure (PHO.OL) President and CEO Kjetil Hestdal discusses the company’s photodynamic technology harnessed in Hexvix and Allumera. Hexvix, branded as Cysview in the U.S., aids … Continue Reading
Read nowInterviews - In an exclusive video interview with PropThink.com, Sagent Pharmaceuticals (SGNT) President and CEO, Jeff Yordon, comments on healthcare reform, addressing pricing controls introduced with the … Continue Reading
Read nowInterviews - Exact Sciences’ (NASDAQ: EXAS) Chief Executive, Kevin Conroy, speaks with PropThink.com during a Global Healthcare Conference in New York City in June. With data from … Continue Reading
Read now